We are live on ! Find out more
CLB icon

Core Laboratories

345 hedge funds and large institutions have $7.51B invested in Core Laboratories in 2013 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 109 increasing their positions, 132 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

281% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 16

22% more funds holding in top 10

Funds holding in top 10: 911 (+2)

18% more capital invested

Capital invested by funds: $6.37B → $7.51B (+$1.14B)

14% more funds holding

Funds holding: 302345 (+43)

4.27% more ownership

Funds ownership: 82.36%86.63% (+4.3%)

17% less repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 132

49% less call options, than puts

Call options by funds: $15.4M | Put options by funds: $30M

Holders
345
Holders Change
+43
Holders Change %
+14.24%
% of All Funds
10.01%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.32%
New
61
Increased
109
Reduced
132
Closed
16
Calls
$15.4M
Puts
$30M
Net Calls
-$14.6M
Net Calls Change
-$14.8M

CLB Hedge Fund Activity: Q4 2013 in Review

345 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q4 2013, worth a combined $7.51B — up 18% from $6.37B a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new CLB positions and 16 closed out — a net gain of 45 holders — while 109 added to existing stakes and 132 trimmed.

The largest buyer was EARNEST Partners, opening a new position worth an estimated $532M. The largest seller was Vontobel Asset Management, cutting an estimated $109M.

  • 345 institutional investors held Core Laboratories (CLB) as of Q4 2013, up from 302 in Q3 2013.
  • Funds reported $7.51B of Core Laboratories stock for Q4 2013, up 18% quarter-over-quarter.
  • 61 funds opened new Core Laboratories positions in Q4 2013 and 16 closed out, a net change of +45 holders.
  • The largest Core Laboratories buyer in Q4 2013 was EARNEST Partners, an estimated $532M added.
  • The largest Core Laboratories seller in Q4 2013 was Vontobel Asset Management, an estimated $109M sold.

Based on aggregated 13F filings for Q4 2013.